Skip to main content
. Author manuscript; available in PMC: 2010 Nov 30.
Published in final edited form as: Nephron. 1987;46(Suppl 1):19–33. doi: 10.1159/000184431

Table II.

Complex nature of coexisting indications for OKT3 therapy in group 1 patients

Indication Number of patients
Renal failure alone 0
Renal failure plus primary graft dysfunction 2
Renal failure plus rejection 3
Primary graft dysfunction alone 1
Primary graft dysfunction plus rejection 3
Rejection alone 6
Renal failure, primary graft dysfunction plus rejection 3

Total 18